{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:43:05Z","timestamp":1790613785242,"version":"4.1.0"},"reference-count":43,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T00:00:00Z","timestamp":1549065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MIUR (Ministero Istruzione Universit\u00e0 e Ricerca)","award":["2015W729WH_007"],"award-info":[{"award-number":["2015W729WH_007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>HIV entry in the host cell requires the interaction with the CD4 membrane receptor, and depends on the activation of one or both co-receptors CCR5 and CXCR4. Former selective co-receptor antagonists, acting at early stages of infection, are able to impair the receptor functions, preventing the viral spread toward AIDS. Due to the capability of HIV to develop resistance by switching from CCR5 to CXCR4, dual co-receptor antagonists could represent the next generation of AIDS prophylaxis drugs. We herein present a survey on relevant results published in the last few years on compounds acting simultaneously on both co-receptors, potentially useful as preventing agents or in combination with classical anti-retroviral drugs based therapy.<\/jats:p>","DOI":"10.3390\/molecules24030550","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T11:31:07Z","timestamp":1549366267000},"page":"550","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["CCR5\/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6154-4330","authenticated-orcid":false,"given":"Fedora","family":"Grande","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Ampliamento Polifunzionale, Via P. Bucci, 87036 Rende (CS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Occhiuzzi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Ampliamento Polifunzionale, Via P. Bucci, 87036 Rende (CS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1110-764X","authenticated-orcid":false,"given":"Bruno","family":"Rizzuti","sequence":"additional","affiliation":[{"name":"CNR-NANOTEC, Licryl-UOS Cosenza and CEMIF.Cal, Department of Physics, University of Calabria, Via P. Bucci, 87036 Rende (CS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Ioele","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Ampliamento Polifunzionale, Via P. Bucci, 87036 Rende (CS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-1595","authenticated-orcid":false,"given":"Michele","family":"De Luca","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Ampliamento Polifunzionale, Via P. Bucci, 87036 Rende (CS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9349-5203","authenticated-orcid":false,"given":"Paola","family":"Tucci","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Ampliamento Polifunzionale, Via P. Bucci, 87036 Rende (CS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Svicher","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aquaro","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Ampliamento Polifunzionale, Via P. Bucci, 87036 Rende (CS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Garofalo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Ampliamento Polifunzionale, Via P. Bucci, 87036 Rende (CS), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jiph.2014.08.003","article-title":"Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV\/AIDS: A systematic review","volume":"8","author":"Cobucci","year":"2015","journal-title":"J. Infect. Public Health"},{"key":"ref_2","first-page":"226","article-title":"Economic Impact of HIV in the Highly Active Antiretroviral Therapy Era\u2014Reflections Looking Forward","volume":"20","year":"2018","journal-title":"AIDS Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Shepherd, A.J., Loo, L., and Mohapatra, D.P. (2013). Chemokine co-receptor CCR5\/CXCR4-dependent modulation of Kv2.1 channel confers acute neuroprotection to HIV-1 glycoprotein gp120 exposure. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076698"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/381667a0","article-title":"HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5","volume":"381","author":"Dragic","year":"1996","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/nm1197-1259","article-title":"In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression","volume":"3","author":"Scarlatti","year":"1997","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/138161208783497714","article-title":"Small molecules anti-HIV therapeutics targeting CXCR4","volume":"14","author":"Grande","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1517\/13543776.2011.550876","article-title":"Small molecule HIV entry inhibitors: Part II. Attachment and fusion inhibitors: 2004-2010","volume":"21","author":"Singh","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cellsig.2004.04.007","article-title":"Chemokine receptor CCR5: Insights into structure, function, and regulation","volume":"16","author":"Oppermann","year":"2004","journal-title":"Cell Signal."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1021\/acs.jmedchem.8b01077","article-title":"Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists","volume":"61","author":"Peng","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"Wu","year":"2010","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chien, H.C., Chan, P.C., Tu, C.C., Day, Y.J., Hung, L.M., Juan, C.C., Tian, Y.F., and Hsieh, P.S. (2018). Importance of PLC-Dependent PI3K\/AKT and AMPK Signaling in RANTES\/CCR5 Mediated Macrophage Chemotaxis. Chin. J. Physiol., 266\u2013279.","DOI":"10.4077\/CJP.2018.BAG584"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"14253","DOI":"10.1038\/ncomms14253","article-title":"Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement","volume":"8","author":"Smith","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1089\/aid.2015.0155","article-title":"The Evolving HIV-1 Epidemic in Warao Amerindians Is Dominated by an Extremely High Frequency of CXCR4-Utilizing Strains","volume":"31","author":"Rangel","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_14","unstructured":"Gupta, S., Prosser, A.R., Cox, B.D., Wilson, L.J., and Liotta, D. (2015, January 22\u201326). Design and synthesis of dual-tropic HIV entry inhibitors that utilize a homologous CCR5\/CXCR4 binding site. Proceedings of the 249th ACS National Meeting & Exposition, Denver, CO, USA."},{"key":"ref_15","unstructured":"Gupta, S., Prosser, A.R., Cox, B.D., Wilson, L.J., and Liotta, D.C. (2014, January 16\u201319). Design and synthesis of Dual Tropic HIV entry inhibitors that utilize a homologous CCR5\/CXCR4 binding site. Proceedings of the 66th Southeast Regional Meeting of the American Chemical Society, Nashville, TN, USA."},{"key":"ref_16","first-page":"5447","article-title":"Maraviroc: A review of its use in HIV infection and beyond","volume":"9","author":"Woollard","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejmech.2017.08.027","article-title":"An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics","volume":"139","author":"Grande","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.186.8.1383","article-title":"Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4","volume":"186","author":"Schols","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jlb.62.1.138","article-title":"Inhibition of replication of HIV in primary monocyte\/macrophages by different antiviral drugs and comparative efficacy in lymphocytes","volume":"62","author":"Aquaro","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm0198-072","article-title":"AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor","volume":"4","author":"Donzella","year":"1998","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"12996","DOI":"10.1128\/JVI.78.23.12996-13006.2004","article-title":"Inhibition of human immunodeficiency virus replication by a dual CCR5\/CXCR4 antagonist","volume":"78","author":"Princen","year":"2004","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1080\/13543784.2016.1254615","article-title":"CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV","volume":"25","author":"Kim","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Surdo, M., Balestra, E., Saccomandi, P., Di Santo, F., Montano, M., Di Carlo, D., Sarmati, L., Aquaro, S., Andreoni, M., and Svicher, V. (2013). Inhibition of dual\/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068076"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1089\/aid.2014.0124","article-title":"Complexity and dynamics of HIV-1 chemokine receptor usage in a multidrug-resistant adolescent","volume":"30","author":"Cavarelli","year":"2014","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"103e1","DOI":"10.1016\/j.cmi.2014.08.002","article-title":"Effect of maraviroc on non-R5 tropic HIV-1: Refined analysis of subjects from the phase IIb study A4001029","volume":"21","author":"Surdo","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e01763-17","DOI":"10.1128\/AAC.01763-17","article-title":"Effects of Maraviroc versus Efavirenz in Combination with Zidovudine-Lamivudine on the CD4\/CD8 Ratio in Treatment-Naive HIV-Infected Individuals","volume":"61","author":"Caruana","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_27","unstructured":"Hubin, T.J., Archibald, S.J., Won, P., Birdsong, O.C., Epley, B.M., Klassen, S.L., and Schols, D. (2013, January 7\u201311). Synthesis and evaluation of transition metal complex dual CXCR4\/CCR5 antagonists. Proceedings of the 245th ACS National Meeting & Exposition, New Orleans, LA, USA."},{"key":"ref_28","unstructured":"Davilla, D., Birdsong, O., Schols, D., Archibald, S., and Hubin, T. (2016, January 13\u201317). Bis- and pendant armed tetraazamacrocycle transition metal complex dual CXCR4\/CCR5 antagonists. Proceedings of the 251st ACS National Meeting & Exposition, San Diego, CA, USA."},{"key":"ref_29","unstructured":"(2019, January 31). Available online: https:\/\/www.swosu.edu\/academics\/jur\/docs\/transitionmetals-v1.pdf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/prot.24184","article-title":"HIV-1 Env gp120 structural determinants for peptide triazole dual receptor site antagonism","volume":"81","author":"Tuzer","year":"2013","journal-title":"Proteins"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Abreu, C.M., Price, S.L., Shirk, E.N., Cunha, R.D., Pianowski, L.F., Clements, J.E., Tanuri, A., and Gama, L. (2014). Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: Inhibition of de novo infection and activation of viral LTR. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097257"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Spina, C.A., Anderson, J., Archin, N.M., Bosque, A., Chan, J., Famiglietti, M., Greene, W.C., Kashuba, A., Lewin, S.R., and Margolis, D.M. (2013). An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003834"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1021\/acsmedchemlett.5b00036","article-title":"Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5\/CXCR4 HIV Entry and Reverse Transcriptase","volume":"6","author":"Cox","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jmgm.2017.02.012","article-title":"Design and computational support for the binding stability of a new CCR5\/CXCR4 dual tropic inhibitor: Computational design of a CCR5\/CXCR4 drug","volume":"75","author":"Taylor","year":"2017","journal-title":"J. Mol. Graph. Model."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/adt.2015.639","article-title":"High-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry Inhibitors","volume":"13","author":"Marin","year":"2015","journal-title":"Assay Drug Dev. Technol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9368","DOI":"10.1128\/JVI.01178-15","article-title":"P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions","volume":"89","author":"Giroud","year":"2015","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Venugopala, K.N., Rashmi, V., and Odhav, B. (2013). Review on natural coumarin lead compounds for their pharmacological activity. BioMed Res. Int.","DOI":"10.1155\/2013\/963248"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2014.12.102","article-title":"Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity","volume":"457","author":"Matsuda","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bmcl.2012.12.034","article-title":"Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells","volume":"23","author":"Kudo","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-5793(91)80362-7","article-title":"Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins","volume":"281","author":"Tozser","year":"1991","journal-title":"FEBS Lett."},{"key":"ref_41","unstructured":"Gorelick, R.J., and Henderson, L.E. (2017). Human Retroviruses and AIDS 1994-Part III, Elsevier."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Leslie, G.J., Wang, J., Richardson, M.W., Haggarty, B.S., Hua, K.L., Duong, J., Secreto, A.J., Jordon, A.P., Romano, J., and Kumar, K.E. (2016). Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005983"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Tan, S., Yang, B., Liu, J., Xun, T., Liu, Y., and Zhou, X. (2017). Penicillixanthone A, a marine-derived dual-coreceptor antagonist as anti-HIV-1 agent. Nat. Prod. Res., 1\u20135.","DOI":"10.1080\/14786419.2017.1416376"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/3\/550\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:30:38Z","timestamp":1760185838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/3\/550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,2]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["molecules24030550"],"URL":"https:\/\/doi.org\/10.3390\/molecules24030550","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,2]]}}}